EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

A randomized trial of nefopam for postoperative pain management in obstructive sleep apnea patients undergoing uvulopalatopharyngoplasty

Eine randomisierte Studie zu Nefopam zur postoperativen Schmerztherapie bei Patient:innen mit obstruktiver Schlafapnoe nach Uvulopalatopharyngoplastik

Saowapark Chumpathong, Peerachatra Mangmeesri, Sriwimon Panyamee, Wish Banhiran, Maythad Uataya

European Archives of Oto-Rhino-Laryngology · 2026-10 · 283 (11) · 7291-7299

DOI: 10.1007/s00405-026-10472-w ↗

Auf einen Blick

Bei 51 Patient:innen nach UPPP senkte Nefopam den Morphinverbrauch innerhalb von 24 h nicht gegenüber Placebo. Auch andere schmerzbezogene Endpunkte unterschieden sich nicht.

Fragestellung

Kann Nefopam den Morphinverbrauch und die postoperative Erholung nach UPPP bei Patient:innen mit obstruktiver Schlafapnoe verbessern?

Methode

Prospektive, explorative, randomisierte, dreifach verblindete Studie; Zuteilung zu Nefopam oder Placebo zusätzlich zur Standard-Multimodalanalgesie.

Ergebnisse

51 Patient:innen wurden analysiert (26 Nefopam, 25 Kontrolle). Medianer 24-h-Morphinverbrauch: 7 mg vs. 5 mg (P = 0,56). Keine signifikanten Unterschiede bei Schmerz, oraler Nahrungsaufnahme, Zufriedenheit oder Lebensqualität.

Schlussfolgerung der Autor:innen

Nefopam wird nach UPPP laut Autor:innen nicht empfohlen, da es den Morphinverbrauch nicht signifikant senkte und schmerzbezogene Outcomes nicht verbesserte.

Kernaussagen

  • Medianer 24-h-Morphinverbrauch: 7 mg vs. 5 mg (P = 0,56)
  • Keine signifikanten Unterschiede bei Schmerz oder Erholung
  • Tachykardie und Schwitzen traten nur in der Nefopam-Gruppe auf

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift European Archives of Oto-Rhino-Laryngology, online erschienen am 16.09.2026. Verfasst von Saowapark Chumpathong und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand. Hauptthemen laut MEDLINE: Analgesics, Non-Narcotic, Nefopam, Otorhinolaryngologic Surgical Procedures, Pain Management. Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Faculty of Medicine Siriraj Hospital, Mahidol University.

Auf einen BlickAbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Uvulopalatopharyngoplasty (UPPP) is a surgical treatment for obstructive sleep apnea that often results in significant postoperative pain. Given the risks associated with opioid use in patients with obstructive sleep apnea, multimodal analgesia is preferred. This study evaluated whether nefopam, a non-opioid analgesic, without respiratory depressive effects, could reduce morphine consumption and improve postoperative recovery in patients undergoing UPPP.

Methods

This prospective, exploratory, randomized, triple-blinded trial enrolled patients scheduled for elective UPPP. Participants were randomly assigned to receive either nefopam or a placebo (normal saline). The nefopam group received a 20 mg intravenous loading dose over 1 h, followed by a continuous infusion of 80 mg over 24 h. Both groups received standard multimodal analgesia. The primary outcome was total morphine consumption within 24 h postoperatively. The secondary outcomes were postoperative pain scores, time to first oral intake, patient satisfaction, quality-of-life scores, and adverse events.

Results

Fifty-one patients were analyzed (nefopam: 26, control: 25). The median 24-hour morphine consumption was 7 mg in the nefopam group and 5 mg in the control group ( P = 0.56). No significant differences were found between groups in postoperative pain scores, time to first oral intake, patient satisfaction, or quality-of-life scores. Adverse event rates were similar, although tachycardia (11.5%) and sweating (3.8%) were observed only in the nefopam group. Subgroup analysis in UPPP alone and extended UPPP surgery likewise revealed no significant differences between groups.

Conclusion

Nefopam is not recommended for pain management following UPPP as it did not significantly reduce morphine consumption or improve pain-related outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Analgesics, Non-NarcoticNefopamOtorhinolaryngologic Surgical ProceduresPain ManagementPostoperative PainSleep Apnea, ObstructiveAdultFemaleHumansMaleMiddle AgedAnalgesics, OpioidDouble-Blind MethodMorphinePain MeasurementPalate, SoftPharynxProspective StudiesTreatment OutcomeUvula

Stichwörter der Autor:innen

Multimodal analgesiaNefopamObstructive sleep apneaPostoperative painUvulopalatopharyngoplasty

Substanzen

Analgesics, Non-NarcoticAnalgesics, OpioidMorphineNefopam

Autor:innen und Institutionen

  • Department of Anesthesiology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
  • Department of Anesthesiology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand. peerachatra.man@mahidol.ac.th.
  • Department of Otorhinolaryngology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.

Förderung

  • Faculty of Medicine Siriraj Hospital, Mahidol University

Zitieren

APA

Chumpathong, S., Mangmeesri, P., Panyamee, S., Banhiran, W., & Uataya, M. (2026). A randomized trial of nefopam for postoperative pain management in obstructive sleep apnea patients undergoing uvulopalatopharyngoplasty. European Archives of Oto-Rhino-Laryngology, 283(11), 7291-7299. https://doi.org/10.1007/s00405-026-10472-w

Vancouver

Chumpathong S, Mangmeesri P, Panyamee S, Banhiran W, Uataya M. A randomized trial of nefopam for postoperative pain management in obstructive sleep apnea patients undergoing uvulopalatopharyngoplasty. European Archives of Oto-Rhino-Laryngology. 2026;283(11):7291-7299. doi:10.1007/s00405-026-10472-w

BibTeX
@article{Chumpathong2026,
  author = {Chumpathong, Saowapark and Mangmeesri, Peerachatra and Panyamee, Sriwimon and Banhiran, Wish and Uataya, Maythad},
  title = {A randomized trial of nefopam for postoperative pain management in obstructive sleep apnea patients undergoing uvulopalatopharyngoplasty},
  journal = {European Archives of Oto-Rhino-Laryngology},
  year = {2026},
  volume = {283},
  number = {11},
  pages = {7291--7299},
  doi = {10.1007/s00405-026-10472-w}
}
Kostenlos starten →